Is immunotherapy the holy grail for pancreatic cancer?

Immunotherapy. 2019 Dec;11(17):1435-1438. doi: 10.2217/imt-2019-0164. Epub 2019 Nov 21.

Authors

Roland Andersson¹, Carlos-Filipe Pereira^{2

3}, Monika Bauden¹, Daniel Ansari¹

Affiliations

¹ Department of Surgery, Clinical Sciences Lund, Lund University & Skåne University Hospital, Lund, Sweden.
² Molecular Medicine & Gene Therapy, Lund Stem Cell Center, Lund University, BMC A12, 221 84, Lund, Sweden.
³ Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.

PMID: 31747808
DOI: 10.2217/imt-2019-0164

No abstract available

Keywords: biomarkers; immune checkpoint inhibitor; immunotherapy; pancreatic cancer; tumor antigenicity.

Publication types

Editorial

MeSH terms

Humans
Immunotherapy / methods*
Pancreatic Neoplasms / immunology
Pancreatic Neoplasms / therapy*
Tumor Microenvironment